Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Haemostasis Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00357084
What this trial is testing

Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Ended earlyNCT05090566
What this trial is testing

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Pfizer 46
Early research (Phase 1)Study completedNCT00004232
What this trial is testing

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Northwestern University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06385483
What this trial is testing

Testing Afatinib as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH - Subprotocol A)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)UnknownNCT00036712
What this trial is testing

Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+9 more
Medical College of Wisconsin 80
Testing effectiveness (Phase 2)UnknownNCT00003163
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
Medical College of Wisconsin 10
Testing effectiveness (Phase 2)Study completedNCT01561352
What this trial is testing

Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis

Who this might be right for
Other Haemostasis DisorderHaemorrhagic Cystitis
Novo Nordisk A/S 7
Testing effectiveness (Phase 2)Looking for participantsNCT05372354
What this trial is testing

Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 260
Not applicableUnknownNCT04952974
What this trial is testing

B-cell Chronic Lymphoid Malignancies Markers

Who this might be right for
Chronic Lymphocytic LeukemiaMarginal Zone LymphomaLymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia+3 more
University Hospital, Strasbourg, France 420
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Not applicableAvailableNCT07215832
What this trial is testing

Karyopharm Expanded Access Program for Selinexor

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell Lymphoma (DLBCL)Sarcoma+5 more
Karyopharm Therapeutics Inc
Testing effectiveness (Phase 2)Active Not RecruitingNCT02773030
What this trial is testing

Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 466
Not applicableStudy completedNCT02422810
What this trial is testing

High-Shear Microfluidic Thrombosis Assay

Who this might be right for
Coagulation Defects, Other and Unspecified
Emory University 16
Large-scale testing (Phase 3)UnknownNCT02991638
What this trial is testing

Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-cell LymphomasChronic Hepatitis B+4 more
The University of Hong Kong 62
Early research (Phase 1)Study completedNCT00470405
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

Who this might be right for
LymphomaSolid Tumor
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Not applicableEnded earlyNCT00918658
What this trial is testing

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 34
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Next Page